WebThe latest price target for . Aldeyra Therapeutics (NASDAQ: ALDX) was reported by HC Wainwright & Co. on March 10, 2024.The analyst firm set a price target for $15.00 expecting ALDX to rise to ... WebApr 10, 2024 · A high-level overview of Aldeyra Therapeutics, Inc. (ALDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
ALDX Aldeyra Therapeutics Inc - Stocktwits
WebLEXINGTON, Mass., March 30, 2024--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the completion of enrollment in the Phase 2 clinical trial of the orally … WebAldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease. Business Wire +9.37%. Jan-12-23 06:37AM. Insiders made the right call by buying US$1.2m Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) stock this year, currently sit on US$349k profit. how do i order checks from charles schwab
Aldeyra Therapeutics Inc ALDX Stock Quote - NASDAQ …
WebApr 6, 2024 · NASDAQ:ALDX Aldeyra Therapeutics - ALDX Insider Trading & Ownership $6.43 -0.09 (-1.38%) (As of 02/9/2024 05:10 PM ET) Compare Today's Range $6.30 $6.57 50-Day Range $5.77 $7.09 52-Week Range $2.36 $7.99 Volume 314,458 shs Average Volume 368,332 shs Market Capitalization $376.54 million P/E Ratio N/A Dividend Yield … WebApr 6, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALDX shares currently have a short interest ratio of 5.0. Learn More on Aldeyra Therapeutics's short interest ratio. WebGet the latest Aldeyra Therapeutics Inc (ALDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … how much money did divergent make